Laura Linares

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Genotypic and Phenotypic Study of Antiviral Resistance Mutations in Refractory Cytomegalovirus Infection.

Genotypic and Phenotypic Study of Antiviral Resistance Mutations in Refractory Cytomegalovirus Infection.

Journal: The Journal of infectious diseases

Published: June 16, 2022

Assessment of UL56 Mutations before Letermovir Therapy in Refractory Cytomegalovirus Transplant Recipients.

Assessment of UL56 Mutations before Letermovir Therapy in Refractory Cytomegalovirus Transplant Recipients.

Journal: Microbiology spectrum

Published: March 28, 2022

Polygenic Innate Immunity Score to Predict the Risk of Cytomegalovirus Infection in CMV D+/R- Transplant Recipients. A Prospective Multicenter Cohort Study.

Polygenic Innate Immunity Score to Predict the Risk of Cytomegalovirus Infection in CMV D+/R- Transplant Recipients. A Prospective Multicenter Cohort Study.

Journal: Frontiers in immunology

Published: March 17, 2022

Gustatory and olfactory dysfunctions in hospitalised patients with COVID-19 pneumonia: a prospective study.

Gustatory and olfactory dysfunctions in hospitalised patients with COVID-19 pneumonia: a prospective study.

Journal: BMJ open

Published: August 18, 2021

BK Virus and Cytomegalovirus Coinfections in Kidney Transplantation and Their Impact on Allograft Loss.

BK Virus and Cytomegalovirus Coinfections in Kidney Transplantation and Their Impact on Allograft Loss.

Journal: Journal of clinical medicine

Published: July 26, 2021

Experience with the use of siltuximab in patients with SARS-CoV-2 infection.

Experience with the use of siltuximab in patients with SARS-CoV-2 infection.

Journal: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia

Published: May 13, 2021

Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infection.

Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infection.

Journal: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia

Published: April 08, 2021

Impact of Inflammatory Response Modifiers on the Incidence of Hospital-Acquired Infections in Patients with COVID-19.

Impact of Inflammatory Response Modifiers on the Incidence of Hospital-Acquired Infections in Patients with COVID-19.

Journal: Infectious diseases and therapy

Published: February 24, 2021

Invasive aspergillosis in solid organ transplantation: Diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study).

Invasive aspergillosis in solid organ transplantation: Diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study).

Journal: Mycoses

Published: February 17, 2021

Use of Anti-Cytokine Therapy in Kidney Transplant Recipients with COVID-19.

Use of Anti-Cytokine Therapy in Kidney Transplant Recipients with COVID-19.

Journal: Journal of clinical medicine

Published: February 12, 2021

Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study.

Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study.

Journal: PloS one

Published: January 11, 2021

Salvage Treatment with Cefiderocol Regimens in Two Intravascular Foreign Body Infections by MDR Gram-Negative Pathogens, Involving Non-Removable Devices.

Salvage Treatment with Cefiderocol Regimens in Two Intravascular Foreign Body Infections by MDR Gram-Negative Pathogens, Involving Non-Removable Devices.

Journal: Infectious diseases and therapy

Published: December 09, 2020

Showing 1-12 of 28

Last Updated: 09/26/2026